As evidence, it has been shown that SALL4 is related to Car resistance in endometrial cancer by inducing epithelial-mesenchymal transition (EMT) and MYC expression, whereas reducing SALL4 expression enhances Car efficiency in endometrial cancer cells [20]. This evidence concerns the gene SALL4 and endometrial cancer.